Your session is about to expire
← Back to Search
Overdose Prevention Intervention for Drug Overdose (Oasis Trial)
N/A
Recruiting
Led By Carl Latkin, PhD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Oasis Trial Summary
This trial is testing whether a targeted, peer-driven intervention can reduce HIV and HCV transmission, as well as overdose risk behaviors, among people who inject drugs.
Who is the study for?
This trial is for current opioid users who have used within the last two weeks. It's aimed at people who inject drugs and are at risk of HIV, hepatitis C, or drug overdose. Participants must be able to engage in the study without mental or physical health issues interfering.Check my eligibility
What is being tested?
The study tests a new peer-driven intervention designed to reduce the risks of HIV, hepatitis C virus transmission, and overdoses among those who inject drugs. It's a pilot program focusing on injection settings.See study design
What are the potential side effects?
Since this is an educational and behavioral intervention rather than a medication-based one, traditional side effects like you'd see with drugs aren't expected. However, participants may experience stress or emotional discomfort.
Oasis Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
HIV/HCV prevention
Overdose prevention
Secondary outcome measures
Overdose behaviors
Overdose behaviors 2
Oasis Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
behavioral training with 6 sessions
Group II: comparisonActive Control1 Intervention
Attention control
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,455 Previous Clinical Trials
2,596,695 Total Patients Enrolled
Johns Hopkins Bloomberg School of Public HealthLead Sponsor
410 Previous Clinical Trials
2,116,665 Total Patients Enrolled
Carl Latkin, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health
5 Previous Clinical Trials
4,042 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have any health issues that prevent me from participating.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental
- Group 2: comparison
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still openings for participation in this clinical trial?
"Affirmative. The details on clinicaltrials.gov confirm that the trial, initially posted April 30th 2022, is presently enrolling participants. About 285 individuals must be recruited from a single medical centre."
Answered by AI
How many participants are eligible to take part in this clinical research?
"Affirmative. Per information accessible on clinicaltrials.gov, this study is currently looking for participants to enrol. The trial was first posted April 30th 2022 and most recently updated September 7th 2022; the research seeks 285 volunteers from a single location."
Answered by AI
Who else is applying?
What state do they live in?
Virginia
How old are they?
65+
What site did they apply to?
Lighthouse Studies at Peer Point
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger